Bank of New York Mellon Corp - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 82 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2023$916,478
-11.6%
451,467
+0.2%
0.00%
Q2 2023$1,036,419
-19.1%
450,617
+6.6%
0.00%
Q1 2023$1,280,722
+31.3%
422,681
+1.0%
0.00%
Q4 2022$975,166
+32.5%
418,527
+8.6%
0.00%
Q3 2022$736,000
-23.5%
385,461
+8.6%
0.00%
Q2 2022$962,000
-12.1%
354,849
-3.4%
0.00%
Q1 2022$1,094,000
-20.3%
367,189
+4.0%
0.00%
Q4 2021$1,373,000
+24.6%
352,953
+37.4%
0.00%
Q3 2021$1,102,000
+51.6%
256,921
+7.1%
0.00%
Q2 2021$727,000
+325.1%
239,992
+366.8%
0.00%
Q1 2021$171,000
-14.5%
51,416
-8.7%
0.00%
Q4 2020$200,000
+257.1%
56,314
+217.5%
0.00%
Q3 2020$56,000
-92.1%
17,737
-93.1%
0.00%
Q4 2019$713,000
+82.4%
256,3270.0%0.00%
Q3 2019$391,000
+11.7%
256,327
+161.6%
0.00%
Q1 2019$350,000
-0.8%
97,968
+6.2%
0.00%
Q4 2018$353,000
-80.5%
92,282
-51.9%
0.00%
Q3 2018$1,813,000
+197.7%
191,857
+129.9%
0.00%
Q2 2018$609,00083,4590.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q4 2020
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 340,000$1,459,0000.53%
RTW INVESTMENTS, LP 4,733,323$20,306,0000.31%
APIS CAPITAL ADVISORS, LLC 70,000$300,0000.29%
Hudson Bay Capital Management LP 1,800,000$7,722,0000.10%
COWEN AND COMPANY, LLC 249,215$1,069,0000.05%
Kerrisdale Advisers, LLC 100,000$429,0000.05%
Woodline Partners LP 496,172$2,129,0000.04%
Shay Capital LLC 60,000$257,0000.03%
Walleye Capital LLC 231,037$991,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 212,700$912,0000.02%
View complete list of ARBUTUS BIOPHARMA CORP shareholders